Pharma — India Patent Cases
1,090 decisions indexed
Page 37 of 37 · 1,090 total
Wockhardt Limited v.Aristo Pharmaceuticals Limited
The Madras High Court ruled in favor of Wockhardt Limited, upholding the original ex parte injunction against Aristo Pharmaceuticals. The court found that despite the respondent's arguments regarding industry practice and generic terms, there was a likelihood of deception or confusion among unwary consumers due to the phonetic and visual similarity between the marks 'SPASMO-PROXYVON' and 'SPASMO-FLEXON'. This decision reinforces the principle that overall similarity is the key factor when assessing trademark infringement in the pharmaceutical sector.
Ciba-Geigy Ltd. v.Torrent Laboratories Ltd.
The Gujarat High Court addressed an opposition filed by Ciba-Geigy against Torrent Laboratories' trademark application for 'ULCIBAN.' The court ultimately ruled in favor of Torrent, finding that despite the inclusion of 'CIBA' within 'ULCIBAN,' there was no likelihood of confusion or deception among consumers. The judgment emphasized that when assessing similarity, the mark must be viewed as a whole, and phonetic/ocular resemblance is not automatically established simply because part of the word matches.
Indo-Pharma Pharmaceutical Works Ltd. v.Citadel Fine Pharmaceuticals Ltd.
The Madras High Court dismissed the appeal filed by Indo-Pharma Pharmaceutical Works Ltd. against Citadel Fine Pharmaceuticals Ltd., upholding the lower court's refusal to grant an interim injunction. The court found that despite both parties operating in the pharmaceutical sector, their products (allopathic syrup vs. Ayurvedic capsules) were distinct in form and character. Crucially, the court held that the prefix 'ENERJ' is a common, descriptive abbreviation of 'energy,' which cannot be monopolized as a trademark, while the suffixes 'JEX' and 'JASE' are phonetically and visually dissimilar enough to prevent consumer confusion.
Burroughs Wellcome (India) Ltd. v.Uni-Sole Pvt. Ltd. & Another
The plaintiffs, owners of the trademark "Septran" and copyright in its carton, sued the defendants for infringement and passing off. The plaintiffs alleged that the defendants were using a deceptively similar mark ("Simptran") and an identical or substantially similar carton design for their product Simptran Tablets. The court passed an interim order restraining the defendant from continuing these infringing activities pending final disposal of the suit.
Burroughs Wellcome (India) Ltd. v.Uni-Sole Pvt. Ltd. And Another
The plaintiffs, owners of the trademark 'Septran' and copyrights in its carton design, sued the defendants for infringing these rights. The plaintiffs alleged that the defendants were deceptively imitating their product ('Simptran Tablets') using a similar carton and mark since 1993.
N.V. Philips Gloeilempenfabrieken Bindhhoven, Holland v.Commissioner Of Income-Tax (No. 1)
This case involved a dispute over whether payments received by N.V. Philips from an Indian company for providing technical knowledge regarding Vitamin D manufacturing constituted a technical assistance fee or royalty. The core issue revolved around the nature of the agreement, which granted exclusive use of confidential processes and information to the Indian company under strict secrecy terms. The court ultimately held that because the process was treated as an exclusive secret property by Philips, the payment bore the character of royalty.
Hoechst Pharmaceuticals Ltd. v.C.V.S. Mani
This case challenged specific amendments made to the Drugs and Cosmetics Rules, 1945, which mandated that certain single-ingredient drugs could only be marketed under their generic or proper scientific name. Petitioners, including Hoechst Pharmaceuticals, argued that this prohibition on using established trade names violated their constitutional rights. The Delhi High Court ultimately struck down the most restrictive clause of the amendment, holding it illegal and ultra vires, while allowing a lesser restriction requiring the proper name to be displayed more prominently than the trade name.
Registrar Of Trade Marks v.Hamdard National Foundation (India)
The Delhi High Court dismissed an appeal by the Registrar of Trade Marks, upholding the single judge's decision to register the trademark 'SAFI' for medicinal preparations. The core issue was whether 'SAFI,' a word meaning 'pure' or 'clear,' was descriptive and thus unregistrable under Section 9 of the Act. The court ruled that even if a mark has an initial reference to quality, it can acquire a secondary meaning through continuous use in trade, making it capable of distinguishing the goods of a particular trader.
Farbewerke Hoechst v.Unichem Laboratories And Ors.
Farbewerke Hoechst sued Unichem Laboratories for infringing Patent No. 58716, which covered the manufacture of sulphonyl-ureas like Tolbutamide (marketed as Rastinon). The defendants claimed non-infringement and challenged the validity of the patent. The court found that the plaintiffs' patent was valid and granted an injunction against the defendants.
Kheshtra Pal Sharama v.Pancham Singh Varma
This 1915 Allahabad High Court judgment addressed a dispute over trademark infringement concerning medicinal products. The applicant, selling 'Sudha Sindhu,' sued the respondent for allegedly infringing his registered trademark through advertisements in Muttra. The court ruled that if the facts alleged by the plaintiff are true—specifically, that the advertisement was calculated to induce confusion—then the trademark has been infringed within the jurisdiction of the local court. Consequently, the lower courts' decision to dismiss the suit on jurisdictional grounds was set aside, allowing the case to proceed.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.